课题基金 / 基金详情

VAAST+: Tool for variant prioritization, risk assessment and disease-gene finding

VAAST+: Tool for variant prioritization, risk assessment and disease-gene finding
VAAST:用于变异优先级排序、风险评估和疾病基因发现的工具
批准号:
8721455
负责人:
Lynn Jorde
金额:
$54.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-01 至 2017-08-31

项目摘要

项目成果

Lynn Jorde的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overarching goal of this proposal is to produce a single deliverable: VAAST+, which will provide innovative and improved solutions for three major bottlenecks in analyses of personal genomes data: variant prioritization, risk assessment and disease-gene finding. Better variant prioritization and risk assessment will aid diagnostic laboratories and clinicians seeking to interpret the impact of rare variants discovered in the course of routine genetic testing; whereas a better tool for disease-gene finding will empower researchers seeking to employ whole-genome and exome sequences to identify novel genes and disease-causing alleles responsible for rare and common diseases. VAAST+ will leverage the VAAST platform, which was developed with support from an NHGRI Grand Opportunity Grant entitled Tool for annotation and analyses of human whole-genome sequence variation data. Doing so will allow us to rapidly implement VAAST+ and distribute it to the research community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human Genetic Variation and Disease
  • 批准号:
    10206753
  • 项目类别:
  • 资助金额:
    $60.49万
  • 财政年份:
    2016
  • 负责人:
    Lynn Jorde
  • 依托单位:
Human Genetic Variation and Disease
  • 批准号:
    10431948
  • 项目类别:
  • 资助金额:
    $58.3万
  • 财政年份:
    2016
  • 负责人:
    Lynn Jorde
  • 依托单位:
Training Program in Genomic Medicine
  • 批准号:
    10632018
  • 项目类别:
  • 资助金额:
    $30.53万
  • 财政年份:
    2016
  • 负责人:
    Lynn Jorde
  • 依托单位:
Human Genetic Variation and Disease
  • 批准号:
    10646423
  • 项目类别:
  • 资助金额:
    $58.3万
  • 财政年份:
    2016
  • 负责人:
    Lynn Jorde
  • 依托单位:
海外基金